Sino Biopharmaceutical Ltd's Fiscal Year is From January To December.
The item "Ebit-Interest-Coverage" stands at 1.30 as of 06/30/2025, the lowest value at least since 03/31/2022, the period currently displayed.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Ebit Interest Coverage" stands at 1.30. This represents a decrease of -51.75 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -56.70 percent compared to the value the year prior.
The 1 year change in percent is -56.70.
The 3 year change in percent is -87.91.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Ebit Interest Coverage | 905,699,262,464.00 |
![]() | Johnson & Johnson - Ebit Interest Coverage | 486,508,953,600.00 |
![]() | AbbVie Inc - Ebit Interest Coverage | 399,570,305,024.00 |
![]() | Roche Holding AG - Ebit Interest Coverage | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Ebit Interest Coverage | 280,205,508,085.11 |